First Phase Clinical Trial of Single Agent MBF-362 in Solid Tumors
Clinical trial NCT05940571 · COMPLETED
Trial details
- NCT number
- NCT05940571
- Sponsor
- Medibiofarma S.L.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-24
- Primary completion
- 2024-11-26
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.